Glucose uptake in normal and insulin-resistant L6 cells
Cell-based study · Differentiated rat L6 skeletal muscle cells; normal and insulin-resistant conditions [1]
EDP increased the glucose-uptake assay readout in normal and insulin-resistant L6 cells. Insulin responsiveness was reduced in the insulin-resistant model. Acute MTT measurements showed no significant viability change at the tested concentrations; this does not establish long-term safety.
| Endpoint | Reported result | Reference |
|---|---|---|
| Relative glucose uptake and acute MTT viability in normal L6 cells | Direction versus control Glucose uptake increased at 10, 30, 50 and 100 μM EDP; MTT viability: NS (p > 0.05) at these concentrations. | [1] |
| Glucose uptake under insulin-resistant conditions | Direction versus insulin-resistant control 10 μM EDP increased uptake; 100 nM insulin alone was not significantly different from the insulin-resistant control. | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- Normal-cell assays: 10, 30, 50 and 100 μM EDP; insulin-resistant assay: 10 μM EDP. Insulin positive comparator: 100 nM.
- Exposure duration
- 30 min EDP exposure after 2 h serum removal.
- Method
- Separate EDP, insulin and insulin + EDP groups, with untreated/blank controls.
- Co-treatment
- Figure 1C includes insulin + EDP; single-agent EDP findings are retained separately.
- Reported limits
- EDP solvent and solvent-matched control are not specified in Methods 4.1–4.3. Figure 1 does not state a panel-specific biological n; Methods describe 10 wells per group and experiments repeated more than three times, which are not treated as 10 independent biological replicates.
Methods and source locations
Compound reported in the paper: Estradiol dipropionate; Compound label in the paper: EDP
Published cellular results for the stated EDP material; no validation of Adooq product lots or clinical efficacy.
Results 2.1; Figure 1A–D; Methods 4.1–4.3 and 4.7
Relative glucose uptake and acute MTT viability in normal L6 cells: Residual medium glucose measured by glucose oxidase/peroxidase colorimetry at 505 nm; MTT readout at 492 nm. No exact bar heights extracted. — Figure 1B and 1D; Results 2.1
Glucose uptake under insulin-resistant conditions: Insulin-resistant model generated by 1 μM insulin for 1 day; blank, insulin, EDP and insulin + EDP groups shown. No combination synergy claim. — Figure 1C; Results 2.1; Methods 4.3